MICROVASCULAR COMPLICATIONS — NEUROPATHY ( R POP-BUSUI , SECTION EDITOR ) Inflammation as a Therapeutic Target for Diabetic Neuropathies

Diabetic neuropathies (DNs) are one of the most prevalent chronic complications of diabetes and a major cause of disability, high mortality, and poor quality of life. Given the complex anatomy of the peripheral nervous system and types of fiber dysfunction, DNs have a wide spectrum of clinical manifestations. The treatment of DNs continues to be challenging, likely due to the complex pathogenesis that involves an array of systemic and cellular imbalances in glucose and lipids metabolism. These lead to the activation of various biochemical pathways, including increased oxidative/nitrosative stress, activation of the polyol and protein kinase C pathways, activation of polyADP ribosylation, and activation of genes involved in neuronal damage, cyclooxygenase-2 activation, endothelial dysfunction, altered Na+/K+-ATPase pump function, impaired C-peptide-related signaling pathways, endoplasmic reticulum stress, and low-grade inflammation. This review summarizes current evidence regarding the role of low-grade inflammation as a potential therapeutic target for DNs.

[1]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[2]  A. Greenberg,et al.  Obesity and the role of adipose tissue in inflammation and metabolism. , 2006, The American journal of clinical nutrition.

[3]  A. Goldfine,et al.  Getting away from glucose: fanning the flames of obesity-induced inflammation , 2009, Nature Medicine.

[4]  A. Krolewski.  Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes , 2015, Diabetes Care.

[5]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[6]  M. Cotter,et al.  Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. , 2008, Current drug targets.

[7]  Nish Chaturvedi,et al.  Vascular risk factors and diabetic neuropathy. , 2005, The New England journal of medicine.

[8]  E. Feldman,et al.  Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons. , 2011, Endocrinology.

[9]  David M. Mosser,et al.  Exploring the full spectrum of macrophage activation , 2010, Nature Reviews Immunology.

[10]  M. Kretzler,et al.  Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice. , 2008, Endocrinology.

[11]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[12]  W. F. Todd,et al.  The Natural History of Acute Charcot’s Arthropathy in a Diabetic Foot Specialty Clinic , 1997, Journal of the American Podiatric Medical Association.

[13]  J. Mege,et al.  Macrophage Polarization in Bacterial Infections , 2008, The Journal of Immunology.

[14]  E. Feldman,et al.  Diabetic neuropathy: cellular mechanisms as therapeutic targets , 2011, Nature Reviews Neurology.

[15]  J. Navarro,et al.  Inflammation and diabetic nephropathy , 2006, Current diabetes reports.

[16]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[17]  E H Wagner,et al.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes. , 1999, Diabetes care.

[18]  ANDREW JM BOULTON.  An Integrated Health Care Approach is Needed : The Global Burden of Diabetic Foot Disease , .

[19]  Paul Martin,et al.  Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.

[20]  P. Low,et al.  Enhanced inflammatory response via activation of NF-κB in acute experimental diabetic neuropathy subjected to ischemia–reperfusion injury , 2006, Journal of the Neurological Sciences.

[21]  J. O’Shea,et al.  Helper T-cell Differentiation and Plasticity: Insights from Epigenetics Introduction , 2022 .

[22]  B. I. Tiftikçioğlu,et al.  Role of inflammation in sensory neuropathy in prediabetes or diabetes , 2016, Acta neurologica Scandinavica.

[23]  S. Sinha,et al.  NEURO-ARTHROPATHY (CHARCOT JOINTS) IN DIABETES MELLITUS , 1972 .

[24]  D. Armstrong,et al.  Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. , 1997, Journal of rehabilitation research and development.

[25]  M. Edmonds,et al.  Number of Circulating CD14-Positive Cells and the Serum Levels of TNF-α Are Raised in Acute Charcot Foot , 2011, Diabetes Care.

[26]  C. Nathan.  Epidemic Inflammation: Pondering Obesity , 2008, Molecular medicine.

[27]  M. Nangle,et al.  Effects of interleukin‐6 treatment on neurovascular function, nerve perfusion and vascular endothelium in diabetic rats , 2010, Diabetes, obesity & metabolism.

[28]  Jasmin Divers,et al.  Prevalence of Diabetes in U.S. Youth in 2009: The SEARCH for Diabetes in Youth Study , 2014, Diabetes Care.

[29]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[30]  E. Collard,et al.  Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice , 2010, PloS one.

[31]  A. Boulton,et al.  A role for mitogen‐activated protein kinases in the etiology of diabetic neuropathy , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  David Bryder,et al.  Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. , 2007, Cell stem cell.

[33]  R. Pop-Busui,et al.  Protective Effects of Cyclooxygenase-2 Gene Inactivation Against Peripheral Nerve Dysfunction and Intraepidermal Nerve Fiber Loss in Experimental Diabetes , 2007, Diabetes.

[34]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[35]  Gerardo Heiss,et al.  Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study , 1999, The Lancet.

[36]  I. Adcock,et al.  NF-kappa B: a pivotal role in asthma and a new target for therapy. , 1997, Trends in pharmacological sciences.

[37]  R. Pop-Busui.  What Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes , 2012, Journal of Cardiovascular Translational Research.

[38]  C. Sommer,et al.  Differential expression of cytokines in painful and painless neuropathies , 2007, Neurology.

[39]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[40]  R. Young,et al.  A Chromatin Landmark and Transcription Initiation at Most Promoters in Human Cells , 2007, Cell.

[41]  L. Lavery,et al.  Mortality of first-time amputees in diabetics: a 10-year observation. , 2009, Diabetes research and clinical practice.

[42]  A. Ndip,et al.  The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy , 2011, Diabetes.

[43]  J. Albers,et al.  Diabetic Neuropathy: Mechanisms, Emerging Treatments, and Subtypes , 2014, Current Neurology and Neuroscience Reports.

[44]  E. Feldman,et al.  Insulin resistance in the nervous system , 2012, Trends in Endocrinology & Metabolism.

[45]  Elizabeth Selvin,et al.  Trends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010Trends in Prevalence and Control of Diabetes in the United States , 2014 .

[46]  A. Jenkins,et al.  Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications , 2008, Diabetes Care.

[47]  R. Pop-Busui,et al.  Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. , 2004, Journal of the American College of Cardiology.

[48]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[49]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. , 1998, Nature.

[50]  J. Albers,et al.  Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study , 2010, Diabetes Care.

[51]  Stuart K. Calderwood,et al.  HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine , 2000, Nature Medicine.

[52]  D. Bluemke,et al.  Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). , 2013, Journal of the American College of Cardiology.

[53]  G. Bruno,et al.  Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study , 2008, Diabetes.

[54]  G. Mamikunian,et al.  Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation , 2011, Experimental diabetes research.

[55]  R. Rosenfeld.  Hope , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[56]  P. Holstein,et al.  Long-term follow-up in diabetic Charcot feet with spontaneous onset. , 2000, Diabetes care.

[57]  Thomas A Milne,et al.  Regulation of MLL1 H3K4 methyltransferase activity by its core components , 2006, Nature Structural &Molecular Biology.

[58]  M. Horowitz,et al.  Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments(Diabetes Care (2010) 33, (2285-2293)) , 2010 .

[59]  É. Hajduch,et al.  The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis , 2013, Scientifica.

[60]  E. Middelkoop,et al.  Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. , 1998, The Journal of investigative dermatology.

[61]  C. Sen,et al.  Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. , 2008, Physiological genomics.

[62]  I. Adcock,et al.  NF-kB: a pivotal role in asthma and a new target for therapy , 1997 .

[63]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[64]  J. Fleg,et al.  Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2010, Diabetes Care.

[65]  A. Morabito,et al.  New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up. , 2001, Diabetes care.

[66]  H. Mühl,et al.  Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. , 2007, The Journal of investigative dermatology.

[67]  P. Sönksen,et al.  Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model. , 2000, Journal of clinical epidemiology.

[68]  M. Comalada,et al.  UR-1505, a New Salicylate, Blocks T Cell Activation through Nuclear Factor of Activated T Cells , 2007, Molecular Pharmacology.

[69]  E. Feldman,et al.  Biology of diabetic neuropathy. , 2013, Handbook of clinical neurology.

[70]  M. Edmonds,et al.  Increased osteoclastic activity in acute Charcot’s osteoarthopathy: the role of receptor activator of nuclear factor-kappaB ligand , 2008, Diabetologia.

[71]  R. Dobrowsky,et al.  Heat Shock Protein 70 Is Necessary to Improve Mitochondrial Bioenergetics and Reverse Diabetic Sensory Neuropathy following KU-32 Therapy , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[72]  P. Elias,et al.  Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation , 2002, Experimental dermatology.

[73]  C. García-Rodríguez,et al.  A New Pharmacological Effect of Salicylates: Inhibition of NFAT-Dependent Transcription1 , 2004, The Journal of Immunology.

[74]  Gregory E Crawford,et al.  Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. , 2010, Immunity.

[75]  R. Goldberg.  Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. , 2009, The Journal of clinical endocrinology and metabolism.

[76]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[77]  Eva L Feldman,et al.  Diabetic neuropathy: clinical manifestations and current treatments , 2012, The Lancet Neurology.

[78]  Rayaz A. Malik,et al.  Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments , 2010, Diabetes Care.

[79]  Cord Sunderkötter,et al.  An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. , 2011, The Journal of clinical investigation.

[80]  J. Skupień,et al.  Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria , 2013, Diabetes Care.

[81]  R. Straub,et al.  Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[82]  N. Callizot,et al.  Interleukin‐6 attenuates the development of experimental diabetes‐related neuropathy , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[83]  J. Hur,et al.  Identification of Factors Associated With Sural Nerve Regeneration and Degeneration in Diabetic Neuropathy , 2013, Diabetes Care.

[84]  Vincent Falanga,et al.  Wound healing and its impairment in the diabetic foot , 2005, The Lancet.

[85]  E. Feldman,et al.  Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy , 2009, Diabetes.

[86]  J. Pfeilschifter,et al.  Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. , 2000, The Journal of investigative dermatology.

[87]  J. Albers,et al.  Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.

[88]  A. Mantovani,et al.  Tumor-associated macrophages. , 1989, Current opinion in immunology.

[89]  N. Petrova,et al.  Charcot neuro‐osteoarthropathy—current standards , 2008, Diabetes/metabolism research and reviews.

[90]  Rodica Pop-Busui,et al.  Cardiac Autonomic Neuropathy in Diabetes , 2010, Diabetes Care.

[91]  D. Dormont,et al.  Macrophage activation switching: an asset for the resolution of inflammation , 2005, Clinical and experimental immunology.

[92]  F. Sutterwala,et al.  Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation , 1997, The Journal of experimental medicine.

[93]  A. Bird,et al.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals , 2003, Nature Genetics.

[94]  H. Ozawa,et al.  Calcitonin gene‐related peptide (CGRP)‐containing nerve fibers in bone tissue and their involvement in bone remodeling , 2002, Microscopy research and technique.

[95]  David G Armstrong,et al.  Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. , 2003, Diabetes care.

[96]  W. Rathmann,et al.  Association of Subclinical Inflammation With Polyneuropathy in the Older Population , 2013, Diabetes Care.

[97]  S. Sinha,et al.  Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). , 1972, Medicine.

[98]  Chrisholm Dj.  The Diabetes Control and Complications Trial (DCCT). A milestone in diabetes management. , 1993 .

[99]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[100]  C. Culmsee,et al.  Neuronal apoptosis in Alzheimer ’ s disease , 2001 .

[101]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[102]  R. Hamman,et al.  Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2050 , 2012, Diabetes Care.

[103]  Inflammation and atherosclerosis: here, there, or everywhere. , 2001, Harvard heart letter : from Harvard Medical School.

[104]  David Bryder,et al.  Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. , 2006, The American journal of pathology.

[105]  T. Lyons,et al.  Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. , 2009, The Journal of clinical endocrinology and metabolism.

[106]  R. Freeman,et al.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management , 2011, Diabetes/metabolism research and reviews.

[107]  K. Jablonski,et al.  Salicylate (Salsalate) in Patients With Type 2 Diabetes , 2013, Annals of Internal Medicine.

[108]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.

[109]  R. Pop-Busui,et al.  Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials , 2014, Current Diabetes Reports.

[110]  S. Gordon.  The macrophage: Past, present and future , 2007, European journal of immunology.

[111]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[112]  A. Krolewski,et al.  Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. , 2008, Journal of the American Society of Nephrology : JASN.

[113]  M. Nathan,et al.  Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial , 1995, Annals of neurology.

[114]  F. Sutterwala,et al.  Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I , 1998, The Journal of experimental medicine.

[115]  A. Goldfine,et al.  Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes , 2008, Clinical and translational science.

[116]  Vishal Kapoor,et al.  Contribution of Bone Marrow–Derived Cells to Skin: Collagen Deposition and Wound Repair , 2004, Stem cells.

[117]  R. Dobrowsky,et al.  Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons. , 2015, ACS chemical neuroscience.

[118]  Ajay K. Singh,et al.  Inhibition of Cytokine Gene Expression by Sodium Salicylate in a Macrophage Cell Line through an NF-κB-Independent Mechanism , 1999, Clinical Diagnostic Laboratory Immunology.

[119]  T. Suda,et al.  Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing. , 2011, Blood.

[120]  G. Pierce.  Inflammation in nonhealing diabetic wounds: the space-time continuum does matter. , 2001, The American journal of pathology.

[121]  H. V. Jagadish,et al.  The identification of gene expression profiles associated with progression of human diabetic neuropathy. , 2011, Brain : a journal of neurology.